v3 Template
G

Galera Therapeutics, Inc.

Healthcare / Biotechnology ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$30.0M
Funding Rounds
1
Last Funding
2023-02-15

About Galera Therapeutics, Inc.

Galera Therapeutics, Inc. is a company focused on pioneering treatments for patients with breast cancer. Their mission is to reduce suffering and improve treatment outcomes by developing novel therapies that enhance the anti-cancer efficacy of current treatments.

Products & Services

Novel Therapies for Breast Cancer:Developing therapies aimed at improving the anti-cancer efficacy of treatments for breast cancer.

Specialties

Breast Cancer Treatments Novel Therapies Anti-cancer Efficacy Improvement

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 30000000
MR: -
FA: 30 million
FAN: 30000000
D: 2023-02-15
FD: 2023-02-15
-
Registered Direct Offering Latest
2023-02-15
$30.0M

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

J. Mel Sorensen

President and CEO, Chairman

J

Joel Sussman

Chief Accounting Officer

A

Andie Collier

Regulatory and Quality

J

Judy Fox

Drug Development

L

Lawrence Alleva

Board Member

K

Kevin Lokay

Member of the Board of Directors

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Galera Therapeutics, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Healthcare / Biotechnology
Company Size
~135 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro